| Aram Gabrielyan Md Corporation | |
|
500 N Central Ave Ste 740 Glendale CA 91203-3953 | |
| (244) 240-4024 | |
| (833) 651-2094 |
| Full Name | Aram Gabrielyan Md Corporation |
|---|---|
| Speciality | Internal Medicine |
| Location | 500 N Central Ave Ste 740, Glendale, California |
| Authorized Official Name and Position | Aram Gabrielyan (PHYSICIAN) |
| Authorized Official Contact | 4244240402 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Aram Gabrielyan Md Corporation 500 N Central Ave Ste 740 Glendale CA 91203-3953 Ph: (424) 424-0402 | Aram Gabrielyan Md Corporation 500 N Central Ave Ste 740 Glendale CA 91203-3953 Ph: (244) 240-4024 |
| NPI Number | 1639823933 |
|---|---|
| Provider Enumeration Date | 02/07/2022 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 3870988967 |
|---|---|
| Medicare Enrollment ID | O20220329000394 |
News Archive
The Earla Dunbar Consumer Award was created to honour Earla Dunbar's legacy. Ms.Dunbar, who will be in Vancouver to present Zoe Whittall the award, was the ADAC/ACTA Consumer Advisory Committee Chairperson since its inception in 2002.
Since its first identification in Asia, highly pathogenic avian influenza-H5N1-has caused significant alarm in the scientific community. While the virus' primary target is birds-tens of millions have already died from it-it is capable of infecting mammals, including humans, causing serious illness and a frightening rate of mortality.
Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.
Treatments for childhood cancer are often intense and carry the risk of lifelong health problems for survivors. An analysis of 23,600 childhood cancer survivors in the Childhood Cancer Survivor Study (CCSS), funded by the National Institutes of Health, found that the rate of severe health problems occurring five or more years after diagnosis has declined over time.
Genzyme, a Sanofi company, announced today Argentina's National Administration of Drugs, Food and Medical Technology has approved once-daily, oral AUBAGIO 14 mg as a new treatment indicated for patients with relapsing forms of multiple sclerosis.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639823933 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | (* (Not Available)) | Primary |
| Provider Name | Aram Gabrielyan |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1770901985 PECOS PAC ID: 0143448258 Enrollment ID: I20191003002729 |
News Archive
The Earla Dunbar Consumer Award was created to honour Earla Dunbar's legacy. Ms.Dunbar, who will be in Vancouver to present Zoe Whittall the award, was the ADAC/ACTA Consumer Advisory Committee Chairperson since its inception in 2002.
Since its first identification in Asia, highly pathogenic avian influenza-H5N1-has caused significant alarm in the scientific community. While the virus' primary target is birds-tens of millions have already died from it-it is capable of infecting mammals, including humans, causing serious illness and a frightening rate of mortality.
Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.
Treatments for childhood cancer are often intense and carry the risk of lifelong health problems for survivors. An analysis of 23,600 childhood cancer survivors in the Childhood Cancer Survivor Study (CCSS), funded by the National Institutes of Health, found that the rate of severe health problems occurring five or more years after diagnosis has declined over time.
Genzyme, a Sanofi company, announced today Argentina's National Administration of Drugs, Food and Medical Technology has approved once-daily, oral AUBAGIO 14 mg as a new treatment indicated for patients with relapsing forms of multiple sclerosis.
› Verified 2 days ago
News Archive
The Earla Dunbar Consumer Award was created to honour Earla Dunbar's legacy. Ms.Dunbar, who will be in Vancouver to present Zoe Whittall the award, was the ADAC/ACTA Consumer Advisory Committee Chairperson since its inception in 2002.
Since its first identification in Asia, highly pathogenic avian influenza-H5N1-has caused significant alarm in the scientific community. While the virus' primary target is birds-tens of millions have already died from it-it is capable of infecting mammals, including humans, causing serious illness and a frightening rate of mortality.
Personalis, Inc. today announced availability of its Genome Services for Research, focusing on accuracy in sequencing, analysis, and interpretation of human genomes. Personalis believes that accuracy is crucial in medicine, both in research and ultimately in clinical use.
Treatments for childhood cancer are often intense and carry the risk of lifelong health problems for survivors. An analysis of 23,600 childhood cancer survivors in the Childhood Cancer Survivor Study (CCSS), funded by the National Institutes of Health, found that the rate of severe health problems occurring five or more years after diagnosis has declined over time.
Genzyme, a Sanofi company, announced today Argentina's National Administration of Drugs, Food and Medical Technology has approved once-daily, oral AUBAGIO 14 mg as a new treatment indicated for patients with relapsing forms of multiple sclerosis.
› Verified 2 days ago
Silva Karchikian, M.d. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 410 Arden Ave, Suite 101, Glendale, CA 91203 Phone: 818-549-9305 Fax: 818-662-8812 | |
Glendale Premier Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 222 W Eulalia St, #201, Glendale, CA 91204 Phone: 818-240-0601 Fax: 818-240-0687 | |
Glenoaks Urgent Care Medical Group, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1100 W Glenoaks Blvd, Glendale, CA 91202 Phone: 818-242-3333 Fax: 818-546-1056 | |
Rubin Manavi, Md, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 214 N Central Ave, Glendale, CA 91203 Phone: 818-241-0970 Fax: 818-638-0024 | |
Armen Nercessian Do Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1122 N Brand Blvd Ste 101, Glendale, CA 91202 Phone: 818-552-2011 Fax: 818-552-2012 | |
Synergy Observation Specialists Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 | |
Andy Chen M.d. A,medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1101 N Pacific Ave Ste 104, Glendale, CA 91202 Phone: 818-552-5000 Fax: 818-552-2959 |